SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?


To: zeta1961 who wrote (652)2/26/2007 8:28:23 PM
From: tuckRead Replies (1) | Respond to of 802
 
One does wonder if the availability and apparent success of gendicine is a factor in the slow enrollment of ADVEXIN trials on these shores. So, as you say, it might behoove INGN to try and enforce its IP there. But I'm just speculating on that factor. And the missing PIII for 241 is a separate issue.

Cheers, Tuck